OBJECTIVE: TO describe the occurrence of extravasation in two patients
receiving low-dose dopamine infusions. CASE SUMMARY: Intravenous dopa
mine was infused peripherally tin the antecubital fossa) to two patien
ts in the cardiac intensive care unit in an attempt to enhance renal b
lood perfusion and urine output. Dopamine extravasation occurred in bo
th patients while the low dose (<3 mu g/kg/min) was infused. Significa
nt local tissue injury was observed in both patients, DISCUSSION: Dopa
mine infusion can cause tissue ischemia or necrosis secondary to vasos
pasm and extravasation. Most of the case reports in the literature hav
e occurred when relatively high doses of dopamine were infused. Only o
ne reported extravasation-induced injury with low-dose dopamine. Altho
ugh low-dose dopamine has a vasodilatory effect in selected tissues, h
igh concentrations achieved locally as a result of extravasation can s
till cause severe vasoconstriction and ischemic tissue injury. CONCLUS
IONS: Low-dose dopamine therapy should be administered with similar pr
ecautions as high-dose dopamine. A central intravenous access should b
e placed for dopamine infusion whenever possible. If this approach is
not feasible, dopamine should be infused only peripherally through a l
ong intravenous catheter into a large vein. A 5-cm angiocatheter that
is 20 gauge or larger is recommended for peripheral dopamine infusion
in our institution. The infusion site should be inspected frequently f
or early detection of extravasation, and changed to a central or a per
ipherally inserted central catheter as soon as possible, especially in
patients at high risk for extravasation.